COR
stock Healthcare Medical DistributionOverall Mixed · 41%
- Fundamentals Fair
- Trajectory Steady
- Leadership Churning
A read across fundamentals, recent price & growth trajectory, and leadership stability. For fun and reading at a glance, not investment advice.
What the indicators say
Bearish 0 of 5 trend signals bullishRSI 37 — soft momentum, not yet oversold.
A mechanical reading of the chart’s indicators — not investment advice.
Key statsas of Jun 3
- Open
- $263.61
- -0.46%
- Close
- $263.61
- -0.46%
- Current
- $263.61
- Prev close
- $264.84
- Today
- 1.21M
- 3-mo avg
- 1.74M
Earningscalendar synced from Yahoo 57d ago
- Most recent
- May 676 days ago
- Next expected
- Aug 5in 15 days
Recent earnings dates
- May 6 76 days ago
- Feb 4 167 days ago
- Nov 5, 2025 258 days ago
- Aug 6, 2025 349 days ago
Past earnings dates come from COR’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.
Fundamentalssynced from SEC 51d ago
Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), COR’s fundamentals read as fair overall.
At 20.2x, the price is a reasonable multiple of the company's annual profit.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 0.8% yield is modest: a small income on top of whatever the share price does.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 0.5% margin is thin; little of each revenue dollar survives as profit.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 103.1% return on equity is strong; the company compounds owners' capital well.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 2.0% return on assets is reasonable for a company of this kind.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
Not enough data to compute debt-to-equity.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 0.90, short-term assets fall short of short-term bills; liquidity is tight.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 9.3% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 3.0% from the prior year: steady profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 51d ago
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $214.0B | $238.6B | $262.2B | $294.0B | $321.3B |
| Net income | $1.5B | $1.7B | $1.7B | $1.5B | $1.6B |
| Diluted EPS | $7.39 | $8.04 | $8.53 | $7.53 | $7.96 |
| Dividend / share | $1.76 | $1.84 | $1.94 | $2.04 | $2.20 |
| Total assets | $57.3B | $56.6B | $62.6B | $67.1B | $76.6B |
| Total liabilities | — | — | — | — | — |
| Shareholder equity | $584.4M | $71.3M | $666.3M | $645.9M | $1.5B |
| Q3-2024 | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $74.2B | $79.1B | $81.5B | $75.5B | $80.7B | $83.7B | $85.9B | $78.4B |
| Net income | $483.5M | $3.4M | $488.6M | $717.9M | $687.4M | -$339.7M | $559.6M | $1.6B |
| Diluted EPS | $2.42 | $0.04 | $2.50 | $3.68 | $3.52 | $-1.74 | $2.87 | $8.40 |
| Dividend / share | $0.51 | $0.51 | $0.55 | $0.55 | $0.55 | $0.55 | $0.60 | $0.60 |
Leadershipsynced from SEC 57d ago
- Mauch Robert P. President & CEO · Director
- Cleary James F Chief Financial Officer
- Battaglia Silvana Executive Vice President
- Campbell Elizabeth S Executive Vice President
- Krikorian Lazarus SVP & Chief Accounting Officer
- Baumann Werner Director
- Clyburn Frank Director
- Cooper Ellen Director
- Durcan Dermot Mark Director
- Greenberg Lon R Director
- Kim Lorence H. Director
- Miller Redonda Director
- Nally Dennis M Director
- Ryerkerk Lori Director
- Tyler Lauren M Director
Officers and board are drawn from COR’s recent SEC ownership filings (Forms 3, 4 and 5).
Notable recent eventspast year
- May 29 Officer or director change reported in an 8-K
- May 6 −17.4% one-day move
- Apr 22 New 6-month low (-18% off peak)
- Mar 17 Officer or director change reported in an 8-K
- Feb 5 +6.7% one-day move
- Feb 4 −8.8% one-day move
- Jan 22 Officer or director change reported in an 8-K
- Aug 27, 2025 Officer or director change reported in an 8-K
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Dividendssynced from Yahoo 52d ago
- 2025 total
- $2.25
- 2026 so far
- $1.202 payments
- 2026 projected
- $2.40+6.7% vs 2025
Projection scales COR’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.
Payment history
- May 15 $0.60
- Feb 13 $0.60
- Nov 14, 2025 $0.60
- Aug 15, 2025 $0.55
- May 16, 2025 $0.55
- Feb 14, 2025 $0.55
- Nov 15, 2024 $0.55
- Aug 9, 2024 $0.51
- May 9, 2024 $0.51
- Feb 8, 2024 $0.51
- Nov 10, 2023 $0.51
- Aug 10, 2023 $0.48
- May 11, 2023 $0.48
- Feb 9, 2023 $0.48
- Nov 10, 2022 $0.48
- Aug 12, 2022 $0.46
- May 13, 2022 $0.46
- Feb 11, 2022 $0.46
- Dec 1, 2021 $1.27
- Nov 12, 2021 $0.46
- Sep 29, 2021 $1.27
- Aug 13, 2021 $0.44
- Jun 29, 2021 $1.27
Recent SEC filingssynced from SEC 51d ago
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-K Annual report
- 8-K Current report